180 related articles for article (PubMed ID: 35027542)
1. ZC3H15 promotes glioblastoma progression through regulating EGFR stability.
Hou J; Xu M; Gu H; Pei D; Liu Y; Huang P; Chang H; Cui H
Cell Death Dis; 2022 Jan; 13(1):55. PubMed ID: 35027542
[TBL] [Abstract][Full Text] [Related]
2. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract][Full Text] [Related]
3. ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway.
Hou J; Huang P; Lan C; Geng S; Xu M; Liu Y; Chang H; Wang Z; Gu H; Wang Y; Yang G; Cui H
Cell Death Discov; 2022 Jan; 8(1):32. PubMed ID: 35064102
[TBL] [Abstract][Full Text] [Related]
4. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
5. Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.
Jiang BG; Wan ZH; Huang J; Li LM; Liu H; Fu SY; Yang Y; Zhang J; Yuan SX; Wang RY; Yang Y; Gu FM; Dong LW; Pan ZY; Zhou WP
Oncotarget; 2016 Jun; 7(24):37238-37249. PubMed ID: 27191988
[TBL] [Abstract][Full Text] [Related]
6. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
[TBL] [Abstract][Full Text] [Related]
7. RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.
Xie S; Hong Z; Li Y; Wang J; Wang J; Li S; Liu Y
Mol Neurobiol; 2022 Aug; 59(8):4703-4717. PubMed ID: 35594003
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
9. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
10. RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway.
Hou J; Liu Y; Huang P; Wang Y; Pei D; Tan R; Zhang Y; Cui H
Cell Death Dis; 2021 Oct; 12(11):967. PubMed ID: 34671019
[TBL] [Abstract][Full Text] [Related]
11. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
[TBL] [Abstract][Full Text] [Related]
12. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AML.
Capalbo G; Mueller-Kuller T; Koschmieder S; Klein HU; Ottmann OG; Hoelzer D; Scheuring UJ
Int J Oncol; 2013 Jul; 43(1):246-54. PubMed ID: 23624947
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Zhou Q; Huang T; Jiang Z; Ge C; Chen X; Zhang L; Zhao F; Zhu M; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
Oncogene; 2020 Mar; 39(10):2140-2155. PubMed ID: 31819169
[TBL] [Abstract][Full Text] [Related]
15. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
[TBL] [Abstract][Full Text] [Related]
16. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
17. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
19. PUF60 promotes glioblastoma progression through regulation of EGFR stability.
Wang F; Peng L; Sun Y; Zhang B; Lu S
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):190-196. PubMed ID: 36335869
[TBL] [Abstract][Full Text] [Related]
20. Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.
Verreault M; Weppler SA; Stegeman A; Warburton C; Strutt D; Masin D; Bally MB
PLoS One; 2013; 8(3):e59597. PubMed ID: 23555046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
